# FDA Inspection 593422 - Baxalta US Incorporated - November 14, 2008

Source: https://www.keypedia.com/records/fda_inspections/baxalta-us-incorporated/cfa17b8a-9dee-46a9-a398-eeb7dc4f23b4
Source feed: FDA_Inspections

> FDA Inspection 593422 for Baxalta US Incorporated on November 14, 2008. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 593422
- Company Name: Baxalta US Incorporated
- Inspection Date: 2008-11-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1287588 - 2025-11-07](https://www.keypedia.com/records/fda_inspections/baxalta-us-incorporated/d2682c02-b624-4e00-acab-b1b62b90fecf)
- [FDA Inspection 1287588 - 2025-11-07](https://www.keypedia.com/records/fda_inspections/baxalta-us-incorporated/7e61ab9f-4cfc-4336-b640-fcc530f737f8)
- [FDA Inspection 1208375 - 2023-05-31](https://www.keypedia.com/records/fda_inspections/baxalta-us-incorporated/f54694b5-ae3d-4d13-b692-423ba650590b)
- [FDA Inspection 1072937 - 2018-11-02](https://www.keypedia.com/records/fda_inspections/baxalta-us-incorporated/4005c3a2-d95d-40ae-a3b6-adc953482e8b)
- [FDA Inspection 998105 - 2016-12-13](https://www.keypedia.com/records/fda_inspections/baxalta-us-incorporated/607da296-d988-451a-b214-a178ebb16585)

Company: https://www.keypedia.com/companies/baxalta-us-incorporated/bb2b5b07-7c9c-4fce-b969-4dc5fa402b64

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d